Selective inhibition of extra-synaptic α5-GABAA receptors by S44819, a new therapeutic agent.
Etherington LA, Mihalik B, Pálvölgyi A, Ling I, Pallagi K, Kertész S, Varga P, Gunn BG, Brown AR, Livesey MR, Monteiro O, Belelli D, Barkóczy J, Spedding M, Gacsályi I, Antoni FA, Lambert JJ.
Etherington LA, et al. Among authors: barkoczy j.
Neuropharmacology. 2017 Oct;125:353-364. doi: 10.1016/j.neuropharm.2017.08.012. Epub 2017 Aug 12.
Neuropharmacology. 2017.
PMID: 28807671